| (AUD) | Jun 2021 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -6.61M | 64.36% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, RHY.AX returned -4.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -34.8% |
| 1 year | -4.3% |
| 5 years | -90.5% |
| All-time high | $1.84 (Oct 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in RHY.AX would be worth today ›No. Rhythm Biosciences Limited has not paid a dividend in the past 12 months.
Rhythm Biosciences Limited is part of the Healthcare sector.
Rhythm Biosciences Limited has a market cap of 31.14M AUD, based on the latest quote.
